{"ticker": {"uuid": "d5faa5b5-21aa-4183-97e6-5c9badcfcdaa", "symbol": "BION", "name": "BB Biotech AG", "exchange": "EBS", "country": "CH", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVDJUT3E1NGpvcmZNUXNuWFZVbTRsUlZnZks3ZXA1dU9NS1FRU2I2c2x0eWhqWm5GOW5zbHl4cWFON1V1MDNjUm9uREZOZnBHN21NUDFhalZmVy16WFZKbHFyVUI5dnZ5Y242N2p6UmVnZ0ZkajEtUFVDSkdqSXZzUmhJbG5IYnpqemxnWk96SHVkSWo2dVJGUk91d2VpUTg3bkJPRnh2YzBYNTFMdUNvbDJiU25NMXBwOS1RSFF0Y3lVWUl2WHEwYS00Tmh5TnJnTk1nb2hHNWdPa3hTWG4wdE9UUk5kLTlZdXVjX3VSODRGS0NvOUNrMG50SmNlY3ZYdUtfTlpNNjE1aVBmbWwxTmpXSi1oZ284SkNNVg?oc=5", "source_name": "TradingView", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTG5jVWNtdnRCUUNLclh5RzJKbU9IUWlxcW5IQXdWZkVBYml1U3lnbGtRNGpWaGd5cThkUGNVa1UzeU9qZEpuUjF6dkY5QVRyRnNwY2RWckhIX3g2ZGJHRTZEaXY3bU5Wa3I0VHpfSGl6c0Rqem0zYUZPclZMUHpxNGtuMlM3eDhvbndiUDVYeVotVG1mWE1lOFgzaWNJYjFIS050dlBFSUN3YkdaUnlnMEI2VGYxcUxzOEh3YWoyeVZtWXRKSjkyMmNJR18zRUJLb1VfdjZSaWxEMWJLS0Y5LXhsYkFZVnQ0?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG publishes its interim report", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNWRkbjlRUnBHSWxhanB0RjVhVnN3elJUVHJWZTNkZ2JYbHJsU1lidjhQYi1QZ29ybWFLOWZiVENYa3hsM3pvUWZZOTJxM1ZQT01kOGwtR21vaEE2ZEFNaWJway03RHB6NnExYmg1QUp6bUtqSDQ1anFCNEFCMFoxclFIMWJULTFJMVdSeGpZMVZmWTA0RW9JRGtCSE4?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of BB Biotech AG (SIX:BION)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE8xUm90SFJ3T0FNTENuTmhkblpHVTRhM1ZNVi1fT0FVblViZGp2UXdIM21ud3lScjFMU0ZXeVE3N2dZbkhjT3lRZXQyVlpGQUxiMzBkb2h4dUNKUG5fU0I2UVhwcUZDYlE?oc=5", "source_name": "TradingView", "published_at": "2022-09-13T13:17:55+00:00", "published_display": "13 Sep 2022 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech ups stake in high conviction stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQQk5mUzZKSS1qWjlzRXBoUUpCQmhudjVja0stVVNuTTZWYWkyQ3Y4OUUyd2ViN29sMzZSMTJiWmt0SHF0UzJMWm4zbkhEQjQwd01fNXl0N3NlU19hdXNWUmpTRDNwMEFYVnRFMk9FclN3dkJKQ1VqRWg0U2s2S0VwcQ?oc=5", "source_name": "QuotedData", "published_at": "2021-06-15T07:00:00+00:00", "published_display": "15 Jun 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG \u2013 Bold Brilliant biotech investor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbF9YVW9qMk5KM0VMSmc5c2VzUXVKRkR3b3hSZlVvbU9OTVlCb1g5ZDlwVGFvMVR6SzhEVEpaSGJ1T3A0eHJEM3lOM0EyOE9oT1VKb0Rlc3pPS1VrZTVDS0dVdG16dmt2ZUF1RjFCajVNU3l2S0dsemROci03V1pYaXJQZEFFdlpn?oc=5", "source_name": "QuotedData", "published_at": "2021-02-11T08:00:00+00:00", "published_display": "11 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG: Target Price Consensus and Analysts Recommendations | BION | CH0038389992", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNUEo5RlpPeEpNNWwwNE1rQWVwdG1RYUlZMkc2WHRJcGczNWo4ZUpHWmJHZVdPLUJCLWV5WG5RU0RYamtURGxpRnQ3TkU4WElaakhSbmE5NW5lVWVXdURiMk9VWWlEQUVsMHc5VnplXzk5ZDZ3VDlvUVBYU0RHNmYyNg?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:12:38+00:00", "published_display": "18 Aug 2020 17:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVDJUT3E1NGpvcmZNUXNuWFZVbTRsUlZnZks3ZXA1dU9NS1FRU2I2c2x0eWhqWm5GOW5zbHl4cWFON1V1MDNjUm9uREZOZnBHN21NUDFhalZmVy16WFZKbHFyVUI5dnZ5Y242N2p6UmVnZ0ZkajEtUFVDSkdqSXZzUmhJbG5IYnpqemxnWk96SHVkSWo2dVJGUk91d2VpUTg3bkJPRnh2YzBYNTFMdUNvbDJiU25NMXBwOS1RSFF0Y3lVWUl2WHEwYS00Tmh5TnJnTk1nb2hHNWdPa3hTWG4wdE9UUk5kLTlZdXVjX3VSODRGS0NvOUNrMG50SmNlY3ZYdUtfTlpNNjE1aVBmbWwxTmpXSi1oZ284SkNNVg?oc=5", "source_name": "TradingView", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTG5jVWNtdnRCUUNLclh5RzJKbU9IUWlxcW5IQXdWZkVBYml1U3lnbGtRNGpWaGd5cThkUGNVa1UzeU9qZEpuUjF6dkY5QVRyRnNwY2RWckhIX3g2ZGJHRTZEaXY3bU5Wa3I0VHpfSGl6c0Rqem0zYUZPclZMUHpxNGtuMlM3eDhvbndiUDVYeVotVG1mWE1lOFgzaWNJYjFIS050dlBFSUN3YkdaUnlnMEI2VGYxcUxzOEh3YWoyeVZtWXRKSjkyMmNJR18zRUJLb1VfdjZSaWxEMWJLS0Y5LXhsYkFZVnQ0?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG publishes its interim report", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNWRkbjlRUnBHSWxhanB0RjVhVnN3elJUVHJWZTNkZ2JYbHJsU1lidjhQYi1QZ29ybWFLOWZiVENYa3hsM3pvUWZZOTJxM1ZQT01kOGwtR21vaEE2ZEFNaWJway03RHB6NnExYmg1QUp6bUtqSDQ1anFCNEFCMFoxclFIMWJULTFJMVdSeGpZMVZmWTA0RW9JRGtCSE4?oc=5", "source_name": "TradingView", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of BB Biotech AG (SIX:BION)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE8xUm90SFJ3T0FNTENuTmhkblpHVTRhM1ZNVi1fT0FVblViZGp2UXdIM21ud3lScjFMU0ZXeVE3N2dZbkhjT3lRZXQyVlpGQUxiMzBkb2h4dUNKUG5fU0I2UVhwcUZDYlE?oc=5", "source_name": "TradingView", "published_at": "2022-09-13T13:17:55+00:00", "published_display": "13 Sep 2022 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech ups stake in high conviction stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQQk5mUzZKSS1qWjlzRXBoUUpCQmhudjVja0stVVNuTTZWYWkyQ3Y4OUUyd2ViN29sMzZSMTJiWmt0SHF0UzJMWm4zbkhEQjQwd01fNXl0N3NlU19hdXNWUmpTRDNwMEFYVnRFMk9FclN3dkJKQ1VqRWg0U2s2S0VwcQ?oc=5", "source_name": "QuotedData", "published_at": "2021-06-15T07:00:00+00:00", "published_display": "15 Jun 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG \u2013 Bold Brilliant biotech investor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbF9YVW9qMk5KM0VMSmc5c2VzUXVKRkR3b3hSZlVvbU9OTVlCb1g5ZDlwVGFvMVR6SzhEVEpaSGJ1T3A0eHJEM3lOM0EyOE9oT1VKb0Rlc3pPS1VrZTVDS0dVdG16dmt2ZUF1RjFCajVNU3l2S0dsemROci03V1pYaXJQZEFFdlpn?oc=5", "source_name": "QuotedData", "published_at": "2021-02-11T08:00:00+00:00", "published_display": "11 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BB Biotech AG: Target Price Consensus and Analysts Recommendations | BION | CH0038389992", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxNUEo5RlpPeEpNNWwwNE1rQWVwdG1RYUlZMkc2WHRJcGczNWo4ZUpHWmJHZVdPLUJCLWV5WG5RU0RYamtURGxpRnQ3TkU4WElaakhSbmE5NW5lVWVXdURiMk9VWWlEQUVsMHc5VnplXzk5ZDZ3VDlvUVBYU0RHNmYyNg?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T17:12:38+00:00", "published_display": "18 Aug 2020 17:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 8, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 8, "score": 50, "total": 8, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 3.65, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 50.6, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": 16.3, "twelve_week_move": 8.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.730698, "market_dynamics_buy_signal": false, "relative_strength": 12.95899, "fair_value_gap": 38.2, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.9538, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, +16.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 4}, {"label": "QuotedData", "count": 2}, {"label": "Barron's", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.4% over one week, +16.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BB BIOTECH AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution"}], "updated_at": "2026-07-17T05:37:43.895174+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}